Please provide your email address to receive an email when new articles are posted on . Diagnosis delays are the main challenge in addressing pediatric epilepsy. Neuromodulation techniques for ...
Fellows will be alternating weekday calls with the on-service attending and 1-2 weekend calls per block. The EMU team will also consist of 1-2 residents, 1-2 Advanced Practice Providers, and 1 EEG ...
PHOENIX -- Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and may come with significant side effects. New options in use or ...
Please provide your email address to receive an email when new articles are posted on . Researchers analyzed records of more than 600 vagus nerve stimulation surgeries. Mean surgery duration for those ...
NAUTILUS is the first and only pivotal clinical study to evaluate neuromodulation therapy for treating drug refractory idiopathic generalized epilepsy Neuromodulation therapy is not currently ...
Andrew N. Wilner, MD: Welcome to Medscape. I'm Dr Andrew Wilner and today I have the pleasure of speaking with Dr Barbara Jobst. Dr Jobst is an epileptologist and professor of neurology at Dartmouth ...
GRAND RAPIDS, Mich. (WOOD) — Both epilepsy and its treatment can vary from person to person, experts say. One in 26 people will have epilepsy in their lifetime, according to Corewell Health. The ...
New options in use or under development include devices and gene and cell therapies aimed at resetting or rehabilitating the brain circuits that cause seizures. Dreamstime/TNS PHOENIX — Medication has ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- NeuroPace, Inc. (NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its RNS System and ...
– New patient implants assigned to New Technology Ambulatory Payment Classification 1580 – End-of-service procedures elevated to Level 5 APC – Effective Jan. 1, 2026, will improve economics for ...
YEHUD, Israel--(BUSINESS WIRE)--CerebralRx, a newly formed spin-off of implantable neuromodulation systems developer BioControl Medical, has announced market entry with the launch of its FitNeS vagus ...